CAR-T ARI-0001 shows high response rates in adult patients with acute lymphoblastic leukemia
Developed by Clínic-IDIBAPS teams as part of the Clínic Barcelona Comprehensive Cancer Centre, this treatment confirms its therapeutic potential in a1
Developed by Clínic-IDIBAPS teams as part of the Clínic Barcelona Comprehensive Cancer Centre, this treatment confirms its therapeutic potential in a1
The Clínic Barcelona Comprehensive Cancer Center (4CB), driven by Hospital Clínic, IDIBAPS, and the University of Barcelona, strengthens its internat1
Hospital Clínic-IDIBAPS is the only hospital in Europe to have fully developed two academic CAR T-cell therapies that have been approved by a regulat1